Cargando…
Quality of life in inflammatory bowel diseases: it is not all about the bowel
BACKGROUND/AIMS: The inflammatory bowel diseases (IBD), ulcerative colitis (UC), and Crohn’s disease (CD) are chronic diseases mostly affecting young patients. As they are diseases accompanying patients for their entire life, and the quality of life (QUOL) interacts with disease activity, improving...
Autores principales: | Keller, Ronald, Mazurak, Nazar, Fantasia, Laura, Fusco, Stefano, Malek, Nisar P, Wehkamp, Jan, Enck, Paul, Klag, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873402/ https://www.ncbi.nlm.nih.gov/pubmed/32093437 http://dx.doi.org/10.5217/ir.2019.00135 |
Ejemplares similares
-
Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease
por: Niepel, Dorothea, et al.
Publicado: (2018) -
Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?
por: Mazurak, Nazar, et al.
Publicado: (2015) -
Breakdown of antimicrobial host defense barrier as trigger of chronic inflammatory bowel diseases
por: Wehkamp, Jan
Publicado: (2011) -
Ustekinumab is effective in biological refractory Crohn’s disease patients–regardless of approval study selection criteria
por: Saman, Sadik, et al.
Publicado: (2019) -
GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting
por: Schoeler, Marc, et al.
Publicado: (2018)